Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved (Q44360452)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2003

Language	Label	Description	Also known as
English	Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved	scientific article published in March 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

author name string

Massenkeil G

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Nagy M

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lawang M

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Rosen O

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Genvresse I

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Geserick G

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dörken B

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Arnold R

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

339-345

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

A general method for isolation of high molecular weight DNA from eukaryotes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Three tetranucleotide polymorphisms for loci: D3S1352; D3S1358; D3S1359.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

A further tetranucleotide repeat polymorphism in the vWF gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Tetranucleotide repeat polymorphism at the D21S11 locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

21 January 2018

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

A highly discriminating octoplex short tandem repeat polymerase chain reaction system suitable for human individual identification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703859

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703859

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44360452&oldid=2206590427"